Skip to main content
Erschienen in: Pediatric Nephrology 1/2018

27.03.2017 | Clinical Quiz

Diabetes in a child on growth hormone therapy: Answers

verfasst von: Melanie Aldridge, Tony Huynh, Jose Prado, Steven J. McTaggart

Erschienen in: Pediatric Nephrology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

1.
Renal cysts and diabetes (RCAD) syndrome; also known as maturity-onset diabetes of the young type 5 (MODY5).
 
2.
Mutation in the hepatocyte nuclear factor-1β gene (HNF1β).
 
3.
Aside from optimal medical management, further therapeutic options for management of growth failure in this child are limited.
 
Literatur
1.
Zurück zum Zitat Hwang DY, Dworschak GC, Kohl S, Saisawat P, Vivante A, Hilger AC, Reutter HM, Soliman NA, Bogdanovic R, Kehinde EO, Tasic V, Hildebrandt F (2014) Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int 85:1429–1433CrossRefPubMedPubMedCentral Hwang DY, Dworschak GC, Kohl S, Saisawat P, Vivante A, Hilger AC, Reutter HM, Soliman NA, Bogdanovic R, Kehinde EO, Tasic V, Hildebrandt F (2014) Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int 85:1429–1433CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504–2508CrossRefPubMed Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504–2508CrossRefPubMed
3.
Zurück zum Zitat Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noel LH, Velho G, Timsit J (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510–517CrossRefPubMed Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noel LH, Velho G, Timsit J (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510–517CrossRefPubMed
4.
Zurück zum Zitat Winter WE (2000) Molecular and biochemical analysis of the MODY syndromes. Pediatr Diabetes 1:88–117CrossRefPubMed Winter WE (2000) Molecular and biochemical analysis of the MODY syndromes. Pediatr Diabetes 1:88–117CrossRefPubMed
5.
Zurück zum Zitat Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, Hennekam RC, Ledermann SE, Rees L, van’t Hoff W, Marks SD, Trompeter RS, Tullus K, Winyard PJ, Cansick J, Mushtaq I, Dhillon HK, Bingham C, Edghill EL, Shroff R, Stanescu H, Ryffel GU, Ellard S, Bockenhauer D (2009) HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 20:1123–1131CrossRefPubMedPubMedCentral Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, Hennekam RC, Ledermann SE, Rees L, van’t Hoff W, Marks SD, Trompeter RS, Tullus K, Winyard PJ, Cansick J, Mushtaq I, Dhillon HK, Bingham C, Edghill EL, Shroff R, Stanescu H, Ryffel GU, Ellard S, Bockenhauer D (2009) HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 20:1123–1131CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Waller SC, Rees L, Woolf AS, Ellard S, Pearson ER, Hattersley AT, Bingham C (2002) Severe hyperglycemia after renal transplantation in a pediatric patient with a mutation of the hepatocyte nuclear factor-1beta gene. Am J Kidney Dis 40:1325–1330CrossRefPubMed Waller SC, Rees L, Woolf AS, Ellard S, Pearson ER, Hattersley AT, Bingham C (2002) Severe hyperglycemia after renal transplantation in a pediatric patient with a mutation of the hepatocyte nuclear factor-1beta gene. Am J Kidney Dis 40:1325–1330CrossRefPubMed
7.
Zurück zum Zitat Moller N, Jorgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177CrossRefPubMed Moller N, Jorgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177CrossRefPubMed
8.
Zurück zum Zitat Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355:610–613CrossRefPubMed Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355:610–613CrossRefPubMed
9.
Zurück zum Zitat Stochholm K, Johannsson G (2015) Reviewing the safety of GH replacement therapy in adults. Growth Hormon IGF Res 25:149–157CrossRef Stochholm K, Johannsson G (2015) Reviewing the safety of GH replacement therapy in adults. Growth Hormon IGF Res 25:149–157CrossRef
10.
Zurück zum Zitat Fine RN, Ho M, Tejani A, Blethen S (2003) Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142:539–545CrossRefPubMed Fine RN, Ho M, Tejani A, Blethen S (2003) Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142:539–545CrossRefPubMed
11.
Zurück zum Zitat Rosenbloom AL (2007) Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options? J Pediatr 150:7–11CrossRefPubMed Rosenbloom AL (2007) Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options? J Pediatr 150:7–11CrossRefPubMed
12.
Zurück zum Zitat Clemmons DR (2012) Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin N Am 41:425–443, vii-viiiCrossRef Clemmons DR (2012) Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin N Am 41:425–443, vii-viiiCrossRef
13.
Zurück zum Zitat Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457–469CrossRefPubMedPubMedCentral Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457–469CrossRefPubMedPubMedCentral
Metadaten
Titel
Diabetes in a child on growth hormone therapy: Answers
verfasst von
Melanie Aldridge
Tony Huynh
Jose Prado
Steven J. McTaggart
Publikationsdatum
27.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 1/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3651-2

Weitere Artikel der Ausgabe 1/2018

Pediatric Nephrology 1/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.